Cytori CEO Calhoun on Stem Cell Therapies, Contract

Sept. 28 (Bloomberg) -- Christopher Calhoun, chief executive officer of Cytori Therapeutics Inc., talks about the company's $4.7 million contract with the U.S. government to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs. The contract may be worth $106 million over five years if certain milestones are met. Calhoun speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Hacker Teen Uses 'Swatting' to Harass Online Gamers
08:29 - Bloomberg's Emily Chang reports on the teenage hacker who admitted to "swatting" online gamers. She speaks on "Bloomberg West." (Source: Bloomberg)
  • How Close Are We to an Uber IPO?
  • The Top Three Things to Watch for at Google I/O
  • U.S. Economy Set Up for Sept. or Oct. Rate Hike: Kleintop